Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Dec 12, 2016 (10 years ago)

Extra-Virt Plus DHA Prenatal/Postnatal Softgel

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-251-30

Affected NDC 76439-0251-30

Compare with the code on your package — it is the most precise check available.

Recalling firm
Virtus Pharmaceuticals Opco II L
NDC code
76439-251-30
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0239-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Virtus Pharmaceuticals Opco II L

All 2016 recalls
Class III · Low risk

VirtPrex Prenatal/Postnatal Tablets

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation Virtus Pharmaceuticals Opco II L NDC 76439-348-30 D-0241-2017
Class I · High risk

Hyoscyamine Sulfate

Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.

Terminated Wrong potency / content Virtus Pharmaceuticals Opco II L NDC 76439-308-10 D-0214-2017

Other cgmp deviation recalls from 2016

All cgmp deviation recalls